Research Library
Peptide Research, Explained
Evergreen guides on purity, documentation, handling, and the compounds themselves — written as research and procurement education. For laboratory research use only.

Sermorelin Preclinical Research: Animal Model Map
A map of the animal and ex vivo models used with GHRH peptides, tied to the molecule each study actually tested.
Read article →
Sermorelin In Vitro: Pituitary Cell Assay Models
What the in vitro literature on GHRH (1-29) peptides reports: cell systems, readouts, controls, concentration conversions and the limits of IGF-1 readouts.
Read article →
AOD-9604 Preclinical Literature: Study by Study
A study-by-study appraisal of AOD-9604 preclinical papers, with models, findings, limitations and gaps in the evidence.
Read article →
Workout Recovery: What the Evidence Shows by Strategy
A strategy-by-strategy look at what meta-analyses and trials report about post-exercise recovery: soreness, muscle-damage markers, inflammation and training adaptation, and where the evidence is thin or mixed.
Read article →
Why Sexual Desire Declines With Age: What Studies Report
A literature-based explainer on age and sexual desire: what large surveys measured, which hormone trends were documented, how psychosocial factors compare, and how researchers study desire circuits in animal models.
Read article →
Why Peptides Matter in Biomedical Research
A literature-based look at why peptides matter in research: their selectivity, their origin in hormone biology, the chemistry used to improve them, and the practical problems researchers face in the laboratory.
Read article →
Nootropic Peptides: Semax and Selank Evidence Map
A research-literature map for Semax and Selank: parent fragments, the BDNF and GABA-gene studies, readouts by question, controls, and the limits of the evidence.
Read article →
Tesamorelin Clinical Literature: A Bench-Scientist Guide
A guide to the published tesamorelin trial abstracts for laboratory readers: design, endpoints, responder analyses and limits. No doses.
Read article →
TB-500 Muscle and Ligament Animal Studies: Endpoints
A methods-focused read of the musculoskeletal animal studies behind TB-500 claims: molecule, route, time point and endpoint class.
Read article →
TB-500 Mechanism: When Thymosin β4 Knockouts Disagree
Two Nature papers and a 2012 knockout study give conflicting answers on thymosin β4 in the heart. What that means for TB-500 experiments.
Read article →
GHK-Cu and BPC-157 Skin Repair Models Compared
A side-by-side map of the published skin and wound models for GHK-Cu and BPC-157, with systems, readouts, vehicle controls and evidence limits.
Read article →
Retatrutide Side Effects: What Preclinical Studies Report
What published preclinical studies and a trial abstract report about gastrointestinal, thyroid and cardiovascular signals for triple-agonist peptides, with limits stated.
Read article →
Sermorelin Half-Life: What Published Studies Measured
Four different half-life quantities for GHRH (1-29) explained: plasma, in vivo, culture medium and vial, with the studies behind each.
Read article →
Semax in Animal Models: A Model Selection Guide
Semax has been studied in ischemia, spinal cord injury, stress and development models in rats. This guide helps a lab choose among them by question, endpoint and limitation.
Read article →
Semax Intranasal Route in Preclinical Research Studies
A literature guide to the intranasal route in published Semax animal studies, with the amounts and schedules as reported and the arithmetic for converting them into a laboratory stock.
Read article →
Semax Cognitive Function Research: Rodent Behavior Models
A reader's guide to the behavioral tests used in published Semax work: passive avoidance, conditioned avoidance, sucrose preference and anxiety models, with what each did and did not show.
Read article →
Semaglutide Cardiovascular Research: Preclinical Models
How preclinical semaglutide vascular studies are designed, what the mouse and receptor-localization data show, and where they stop.
Read article →
Semaglutide Animal Models: Choosing a Species
A question-first guide to species and model selection in published semaglutide animal studies, with cross-species caveats.
Read article →
Semaglutide Research Update: 2025–2026 Preclinical Papers
A neutral reading guide to 2025–2026 semaglutide preclinical papers and what each means for a research laboratory.
Read article →
Selank Research Peptide: What the Evidence Shows
An evidence map for Selank: five tiers of preclinical data, how to word each finding, and what remains unresolved.
Read article →
Selank Anxiolytic Peptide Research: Models and Readouts
How rodent anxiety models, strain differences and molecular readouts shape what Selank studies can and cannot show.
Read article →
Selank in Animal Models: Preclinical Findings Reviewed
What published animal and tissue studies report about Selank: gene-expression panels, a morphine-withdrawal rat model, spleen inflammation genes and the limits of the evidence.
Read article →
AOD-9604 in Rodent Models: Obese Mice and Zucker Rats
A model-by-model reading of the published rodent studies on AOD-9604, the hGH 176-191 fragment: designs, reported results, controls and limits.
Read article →
Cagrilintide Half-Life and Preclinical Pharmacokinetics
A research explainer on cagrilintide pharmacokinetics: what half-life means, albumin binding by lipidation, bioanalysis design, and formula-only stock concentration math.
Read article →84 articles in Preclinical